(Q36293497)

English

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis (English)

1 reference

Europe PubMed Central

13 August 2017

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

Jacqueline Palace

6

object named as

J Palace

1 reference

Europe PubMed Central

13 August 2017

Per Soelberg Sørensen

1

object named as

P S Sørensen

1 reference

Europe PubMed Central

13 August 2017

Kjell-Morten Myhr

5

object named as

K-M Myhr

1 reference

Europe PubMed Central

13 August 2017

author name string

F Deisenhammer

2

1 reference

Europe PubMed Central

13 August 2017

P Duda

3

1 reference

Europe PubMed Central

13 August 2017

R Hohlfeld

4

1 reference

Europe PubMed Central

13 August 2017

C Polman

7

1 reference

Europe PubMed Central

13 August 2017

C Pozzilli

8

1 reference

Europe PubMed Central

13 August 2017

C Ross

9

1 reference

Europe PubMed Central

13 August 2017

EFNS Task Force on Anti-IFN-beta Antibodies in Multiple Sclerosis

10

1 reference

Europe PubMed Central

13 August 2017

publication date

1 November 2005

1 reference

Europe PubMed Central

13 August 2017

European Journal of Neurology

1 reference

Europe PubMed Central

13 August 2017

12

1 reference

Europe PubMed Central

13 August 2017

11

1 reference

Europe PubMed Central

13 August 2017

817-827

1 reference

Europe PubMed Central

13 August 2017

Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Interspecific allometry of the brain and brain regions in parrots (psittaciformes): comparisons with other birds and primates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

A sensitive radioimmunoprecipitation assay for assessing the clinical relevance of antibodies to IFN beta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

The clinical impact of interferon beta antibodies in relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Neutralising antibodies to interferon beta during the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Neutralizing antibodies reduce MxA protein induction in interferon-beta-1a-treated MS patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

A novel and rapid assay for the detection of neutralizing antibodies against interferon-beta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01386.X

21 January 2018

Identifiers

10.1111/J.1468-1331.2005.01386.X

1 reference

Europe PubMed Central

13 August 2017

release_bpgds5ap4fahjmmoqcfwfs53fa

1 reference

https://api.fatcat.wiki/v0/release/bpgds5ap4fahjmmoqcfwfs53fa

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36293497&oldid=2055585519"